Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
Quick Stats
Jul 02, 202656.8
AI Score
HOLD0.76
Volume Ratio
Aug 10, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
KYMR Stock Summary
Last updated Jul 02, 2026
KYMR is currently trading at $113.51, positioned above its 200-day moving average of $76.42, indicating a long-term uptrend. The stock has a 52-week range of $36.65 to $130.05.
Technical Analysis: The 50-day moving average stands at $86.77, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 72.082, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.029, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates KYMR at 56.8/100 with a HOLD recommendation.
KYMR (Kymera Therapeutics, Inc. Common Stock) Indicators
Last updated Jul 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 72.082 |
| CMF (20) | -0.029 |
| ROC (10) | 26.263 |
| ADX (14) | 44.942 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 8.703 |
| AROONOSC (14) | 64.286 |
| WILLAMS %R (14) | -34.806 |
| MFI (14) | 62.503 |
KYMR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
KYMR Price vs Max Options Open Interest
KYMR Max Change In Options Open Interest
KYMR Options - Sort by Max open Interest (near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KYMR Daily Out of Money Options - Sort by Max open Interest (near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KYMR Daily In the Money Options - Sort by Max open Interest (near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KYMR Most Active Options by Volume(near term)
4th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Kymera Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
KYMR Moving Averages Analysis
Kymera Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 02, 2026
Kymera Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 02, 2026
KYMR (Kymera Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jul 02, 2026
| Days | MA |
|---|---|
| 10 | 106.43 |
| 20 | 93.71 |
| 30 | 88.76 |
| 50 | 86.77 |
| 100 | 85.48 |
| 200 | 76.42 |
KYMR Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 9.4 billion |
| Earnings/Share ($) | -3.57 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.5156 |
| EPS Estimate Next Year ($) | -4.3461 |
| WallStreet Target Price ($) | 123.7619 |
| Most Recent Quarter |